RxDoctor Payments Data

Angela Negron

Family · Colleyville, TXNPI 1679091425

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $102,270 of the $112,432 with a category attached, or 91.0%. AbbVie accounts for 99.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $44,393 and has fallen 53.2% since, to $20,760 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,432in general payments, 2019–2025

Across 229 payments — averaging $490.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$112K
  • Galderma Laboratories, L.p.$379
  • Boehringer Ingelheim$120
  • Davol Inc.$69
  • Abbott$29
  • Revance Therapeutics, Inc.$27
  • plus $25 from 1 others

What the payments were for

  • Speaking & faculty fees$102,27091%
  • Travel & lodging$5,1855%
  • Food & beverage$4,9774%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)210$111,783
Galderma Laboratories, L.p.14$379
Boehringer Ingelheim1$120
Davol Inc.1$69
Abbott1$29
Revance Therapeutics, Inc.1$27
Vertex1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,432 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Colleyville

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →